NCT03716648

Brief Summary

In this prospective randomized cross-over trial, 3 different titration procedures will be compared:

  1. 1.titration of the mandibular advancement device (MAD) in the home setting based on both the physical limits of the patient's mandibular protrusion and the resolution of subjective complaints, as currently often used in routine clinical practice;
  2. 2.an overnight titration PSG using the remotely controlled mandibular positioner (RCMP) with stepwise mandibular protrusion until respiratory events are reduced and
  3. 3.incremental protrusion of the mandible during DISE using the RCMP until upper airway collapse at all collapsible levels is eliminated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 9, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 23, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

May 22, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 7, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 7, 2021

Completed
Last Updated

July 30, 2021

Status Verified

July 1, 2021

Enrollment Period

1.9 years

First QC Date

October 9, 2018

Last Update Submit

July 29, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • The amount of protrusion (mm)

    The protrusive position that was predicted as the effective target protrusive position during each titration method (subjective titration, RCMP titration PSG and RCMP titration DISE) will be assessed and compared between the different titration methods.

    After the patient underwent the three titration procedures, so approximately 4 months after start of the study

Secondary Outcomes (1)

  • The apnea/hypopnea index (AHI) derived from the polysomnographic evaluation.

    After the patient underwent the three titration procedures, so approximately 4 months after start of the study

Other Outcomes (3)

  • Visual analogue scale for snoring

    After the patient underwent the three titration procedures, so approximately 4 months after start of the study

  • Epworth sleepiness scale

    After the patient underwent the three titration procedures, so approximately 4 months after start of the study

  • Checklist Individual Strenght

    After the patient underwent the three titration procedures, so approximately 4 months after start of the study

Study Arms (3)

Subjective titration

ACTIVE COMPARATOR

After fitting the MAD, there is a 1-month period during which the patients get used to wearing the device and titrate the MAD based on improvement of subjective complaints. The actual mechanism of titration will be individually trained with each patient.

Device: subjective titration

DISE-assisted titration

EXPERIMENTAL

Incremental protrusion of the mandible during drug-induced sleep endoscopy using the remotely controlled mandibular positioner until upper airway collapse at all collapsible levels is eliminated.

Diagnostic Test: DISE-assisted titration

PSG-guided titration

EXPERIMENTAL

An overnight titration polysomnograph using the remotely controlled mandibular positioner with stepwise mandibular protrusion until respiratory events are reduced.

Diagnostic Test: PSG-guided titration

Interventions

Titration of the mandibular position with the remotely controlled mandibular positioner during drug-induced sleep endoscopy.

DISE-assisted titration
PSG-guided titrationDIAGNOSTIC_TEST

Titration of the mandibular position with the remotely controlled mandibular positioner during drug-induced sleep endoscopy.

PSG-guided titration

Titration of the mandibular position based on subjective improvement in symptoms like snoring and excessive daytime sleepiness.

Subjective titration

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with moderate to severe obstructive sleep apnea (OSA) (obstructive AHI (oAHI) ≥ 15/h)
  • BMI \< 30 kg/m²
  • Age \> 18 year
  • PSG \< 2 years old with stable body weight (+/- 5 kg), no ENT surgery since most recent PSG and stable clinical condition
  • Normal clinical and radiological (incl. OPG), periodontal en temporomandibular joint examination
  • Subject is capable of giving informed consent
  • No documented abuses (alcohol, drugs, …)

You may not qualify if:

  • Edentulous patients
  • Insufficient teeth to support the mandibular advancement device
  • Active periodontal problems including tooth mobility
  • Active temporomandibular joint dysfunction
  • Limited maximum protrusive capacity (\<6 mm)
  • Limited vertical opening (\<25 mm)
  • Enlarged palatine tonsils (Grade IV tonsils)
  • Degenerative neuromuscular disorders
  • Pregnancy or willing to become pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Antwerp

Antwerp, Belgium

Location

Related Publications (1)

  • Dieltjens M, Braem MJ, Op de Beeck S, Vroegop AVMT, Kazemeini E, Van de Perck E, Beyers J, Kastoer C, Wouters K, Willemen M, Verbraecken JA, Vanderveken OM. Remotely controlled mandibular positioning of oral appliance therapy during polysomnography and drug-induced sleep endoscopy compared with conventional subjective titration in patients with obstructive sleep apnea: protocol for a randomized crossover trial. Trials. 2019 Oct 29;20(1):615. doi: 10.1186/s13063-019-3698-4.

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Olivier Vanderveken, MD, PhD

    University Hospital, Antwerp

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Randomized, crossover study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
prof. dr. Olivier Vanderveken, MD, PhD

Study Record Dates

First Submitted

October 9, 2018

First Posted

October 23, 2018

Study Start

May 22, 2019

Primary Completion

April 7, 2021

Study Completion

April 7, 2021

Last Updated

July 30, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations